Literature DB >> 17504659

Allergic reactions to nonsteroidal anti-inflammatory drugs: is newer better?

M Pilar Berges-Gimeno1, Joaquín Martín-Lázaro.   

Abstract

In clinical practice, physicians may find it difficult to recognize the differences between allergic and pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) and to manage each type of reaction. This paper reviews all the information presently available in order to clarify main problems related to NSAID reactions and to highlight key strategies to handle these reactions.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17504659     DOI： 10.1007/s11882-007-0028-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


  38 in total

1.  Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria.

Authors:  Riccardo Asero
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

2.  Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.

Authors:  Pär Gyllfors; Grazyna Bochenek; John Overholt; Diane Drupka; Maria Kumlin; James Sheller; Ewa Nizankowska; Peter C Isakson; Filip Mejza; James B Lefkowith; Sven-Erik Dahlén; Andrew Szczeklik; John J Murray; Barbro Dahlén
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

3.  Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.

Authors:  D D Stevenson; R A Simon
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

4.  Anaphylaxis to celecoxib.

Authors:  M B Levy; J N Fink
Journal:  Ann Allergy Asthma Immunol       Date:  2001-07       Impact factor: 6.347

5.  Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.

Authors:  Joaquin Quiralte; Julio Delgado; Blanca Sáenz de San Pedro; Esperanza López-Pascual; Maria Angustias Nieto; Nancy Ortega; Jose Fernando Florido; José Conde
Journal:  Ann Allergy Asthma Immunol       Date:  2004-10       Impact factor: 6.347

6.  Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.

Authors:  Mario Sánchez-Borges; Fernan Caballero-Fonseca; Arnaldo Capriles-Hulett
Journal:  Ann Allergy Asthma Immunol       Date:  2005-01       Impact factor: 6.347

7.  Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions.

Authors:  Joaquín Quiralte; Blanca Sáenz de San Pedro; J José Fernando Florido
Journal:  Ann Allergy Asthma Immunol       Date:  2002-07       Impact factor: 6.347

Review 8.  Analgesics, allergy and asthma.

Authors:  A Szczeklik
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects.

Authors:  P E Christie; P Tagari; A W Ford-Hutchinson; S Charlesson; P Chee; J P Arm; T H Lee
Journal:  Am Rev Respir Dis       Date:  1991-05

10.  Sensitivity to aspirin: a new serological diagnostic method.

Authors:  Z Daxun; W M Becker; K H Schulz; M Schlaak
Journal:  J Investig Allergol Clin Immunol       Date:  1993 Mar-Apr       Impact factor: 4.333
View more
  3 in total

1.  Salicylate selectively kills cochlear spiral ganglion neurons by paradoxically up-regulating superoxide.

Authors:  Lili Deng; Dalian Ding; Jiping Su; Senthilvelan Manohar; Richard Salvi
Journal:  Neurotox Res       Date:  2013-03-15       Impact factor: 3.911

2.  A consensus parameter for the evaluation and management of angioedema in the emergency department.

Authors:  Joseph J Moellman; Jonathan A Bernstein; Christopher Lindsell; Aleena Banerji; Paula J Busse; Carlos A Camargo; Sean P Collins; Timothy J Craig; William R Lumry; Richard Nowak; Jesse M Pines; Ali S Raja; Marc Riedl; Michael J Ward; Bruce L Zuraw; Deborah Diercks; Brian Hiestand; Ronna L Campbell; Sandra Schneider; Richard Sinert
Journal:  Acad Emerg Med       Date:  2014-04       Impact factor: 3.451

3.  World allergy organization guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  World Allergy Organ J       Date:  2011-02-23       Impact factor: 4.084
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.